# A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19.

> **NCT05787288** · EARLY_PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 240 (estimated)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **BIOLOGICAL:** Extracellular Vesicles from Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT05787288
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-23
- **Primary completion:** 2024-01-23
- **Final completion:** 2025-01-23
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787288, "A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05787288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*